The Patent Lawyer
NewsThe latest IP news – to join our panel of Patent news correspondents, please contact us
UKIPO finds AI content-moderation system not shown to infringe patent
The UK Intellectual Property Office (UKIPO) has concluded that an AI-powered content-moderation system offered by Unitary Ltd. has not been shown to infringe a patent owned by Lighthouse Technologies Limited. In Opinion 11/26, issued on September 23, the UKIPO...
Sibionics challenges Abbott patent in latest glucose-monitoring dispute
Chinese medical-device company Sibionics has denied allegations that it infringes Abbott's patented glucose-monitoring technology and is challenging the validity of a patent protecting technology used in Abbott's FreeStyle wearable systems. The development was...
US ITC opens patent probe into Samsung, Apple, and Google over audio technology
BoomCloud 360 alleges that devices incorporating spatial-audio technologies infringe three US patents and seeks a limited exclusion order and cease-and-desist orders. The US International Trade Commission (ITC) has opened a Section 337 investigation into Apple,...
Stratasys wins $27.6m patent verdict against Bambu Lab as second trial looms
A Texas federal jury has found four Bambu Lab entities liable for willful infringement of four Stratasys patents covering 3D-printing technologies, awarding approximately $27.6 million in past damages in the first of two related patent cases. Stratasys has secured a...
Daiichi Sankyo loses six Chinese patent-linkage cases over mirogabalin
CNIPA reportedly finds generic versions of two dosage strengths fall outside three Daiichi Sankyo formulation patents. Daiichi Sankyo has lost six Chinese patent-linkage cases concerning generic versions of mirogabalin after China's National Intellectual Property...
Insights and Best Practices in IP – Life Sciences Field | 2026 Report
How leading life sciences IP teams are adapting to complexity, risk, and rapid change Download the full report to access detailed insights, practitioner perspectives, and best practices shaping IP strategy in life sciences today: Insights and Best Practices in IP -...
“Clearing the way” in Indian patent law: an equitable consideration in interim injunctions
The principle of "clearing the way" has become a significant, though non-statutory, aspect of Indian patent litigation, particularly in cases involving interim injunctions. This concept, borrowed from UK and European patent law, expects a party intending to enter a...
More than 100 companies join Open Invention Network as it evolves to OIN 2.0
Since 2005, Open Invention Network (OIN) has continued in its mission of protecting and promoting open source software (OSS) from patent threats. Its efforts have shielded the open source community from patent aggression, enabling new kinds of industries to take root...
The corporate IP tech stack 2026: what in-house teams should demand from AI tools
By 2026, artificial intelligence will no longer be a “nice to have” in corporate IP departments. It will be a baseline requirement for managing invention capture, patent quality, portfolio scale, and legal risk. That transition is already well underway. A 2025 LawNext...
Mewburn Ellis achieves Great Place To Work™ Certification for second consecutive year
LONDON – European Intellectual Property law firm, Mewburn Ellis, today announces that it has been awarded the Great Place To Work™ Certification 2025 by Great Place to Work ®, marking the firm’s second consecutive year receiving the distinction. The internationally...
Clarivate reveals Top 100 Global Innovators 2026
The Top 100 organizations lead the way in innovation, contributing an exceptional 16% of the world’s highest-strength AI inventions. London, UK, January 21, 2026 - Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the...
The hidden cost of missed inventions: how AI helps corporations capture R&D innovation before it disappears
For most large R&D-driven organizations, the biggest innovation risk is not competitors—it is silence. Every year, thousands of potentially patentable inventions never make it into an invention disclosure, let alone a patent filing. They remain buried in...
Drug Repurposing and Repositioning: March 19, 2026
Drug repurposing continues to offer significant opportunities to bring treatments to patients faster and at lower development risk. However, success increasingly depends on getting regulatory strategy, reimbursement pathways, and IP protection right from the outset....
EIP launches Visser AI®, a new AI-enabled patent service
London, January 12, 2026 – EIP today announces the launch of Visser AI®, a patent service delivered by a specialist team of patent attorneys supported by artificial intelligence (AI) tools. Visser AI applies a different service model across patent work, including...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.













